Amoeba SA (FR:ALMIB) has released an update.
Amoéba SA, a Lyon-based greentech company, aims to revolutionize the treatment of microbiological risks in agriculture and cosmetics with its patented biological solutions. In pursuit of replacing conventional chemicals, Amoéba has made significant strides by securing approval for its biocontrol products in the US and a recommendation in Europe. The company, which is part of the Euronext Growth market and the BPI Excellence network, reports a total of 49,659,963 shares and voting rights as of June 2024.
For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.
